Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
ACS updates prostate cancer screening guidance
The ACS has updated its guideline for prostate cancer screening as it drives to boost detection of the disease before it spreads.
Patrick McGuire
Nov 13, 2026 8:03am
Siemens Healthineers rebrands, carves out diagnostics biz
Nov 6, 2026 2:34am
Bracco invests $230M in first US manufacturing facility
Oct 30, 2026 7:41am
Roche launches differential diagnosis test for mesothelioma
Oct 30, 2026 3:54am
Labcorp buys up Millennium Health
Oct 27, 2026 5:36am
EQT buys molecular diagnostics specialist Qiagen in a €10.8B deal
Oct 23, 2026 9:58am